Related Experiment Video

Updated: May 29, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Impact of medications on bacterial growth in syringes

M Kerenyi1, Z Borza, C Csontos

  • 1Department of Medical Microbiology, University of Pecs, Pecs, Hungary. monika.kerenyi@aok.pte.hu

The Journal of Hospital Infection
|August 26, 2011
PubMed

Insights

Intensive care unit syringes showed a 16% contamination rate. Routine 6-hour changes can reduce bacterial spread from intravenous medication administration.

Area of Science:

  • Infection Control
  • Clinical Microbiology
  • Intensive Care Medicine

Background:

  • Syringes are critical for intravenous medication delivery in intensive care units (ICUs).
  • Potential for microbial contamination of syringes poses a risk to patient safety.

Purpose of the Study:

  • To determine the contamination rate of syringes used for intravenous medications in an ICU setting.
  • To compare microbial isolates from syringes with those from patient blood cultures.
  • To identify factors associated with higher syringe contamination rates.

Main Methods:

  • Syringes used for intravenous medication administration in an ICU were cultured.
  • Microbial isolates from syringes were compared to positive blood cultures from the same patients.
  • Contamination rates were analyzed, considering drug types administered.

Main Results:

  • The overall syringe contamination rate was 16%.
  • Syringes used for bacterial growth-supporting drugs like insulin exhibited higher contamination rates.
  • A significant proportion of syringe contaminants were consistent with blood culture isolates.

Conclusions:

  • Routine changing of syringes every 6 hours is recommended to minimize contamination risk.
  • Enhanced vigilance is needed for syringes containing medications that support bacterial proliferation.
  • Implementing standardized protocols for syringe management is crucial for patient safety in ICUs.

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria08:11

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria

Published on: July 6, 2013

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...